Global Gene Therapy On Cardiovascular Disease Competitive Landscape Professional Research Report 2024

Global Gene Therapy On Cardiovascular Disease Competitive Landscape Professional Research Report 2024



Research Summary

Gene therapy for cardiovascular diseases involves the use of genetic interventions to address underlying issues contributing to heart-related disorders. This therapeutic approach aims to modify or introduce specific genes to improve the function of the cardiovascular system. In the context of cardiovascular diseases, gene therapy may target conditions such as ischemic heart disease, heart failure, or genetic disorders affecting cardiac function. Strategies include enhancing blood vessel formation, promoting cell survival, or modulating the expression of genes associated with cardiac health. Researchers are exploring gene therapy approaches to improve angiogenesis, reduce inflammation, and enhance myocardial function. While gene therapy for cardiovascular diseases is still in the experimental stage, early clinical trials and preclinical studies suggest the potential for novel treatment options to address the complex mechanisms involved in these conditions, offering hope for more effective and targeted interventions in the future.

According to DIResearch's in-depth investigation and research, the global Gene Therapy On Cardiovascular Disease market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.

The major global manufacturers of Gene Therapy On Cardiovascular Disease include Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Spark Therapeutics, Akcea Therapeutics, bluebird bio, Sunway Biotech, SIBIONO, AnGes, Human Stem Cells Institute, Orchard Therapeutics etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Gene Therapy On Cardiovascular Disease. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Gene Therapy On Cardiovascular Disease market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Gene Therapy On Cardiovascular Disease market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Gene Therapy On Cardiovascular Disease industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Gene Therapy On Cardiovascular Disease Include:

Biogen

Novartis

Gilead Sciences

Sarepta Therapeutics

Alnylam Pharmaceuticals

Amgen

Spark Therapeutics

Akcea Therapeutics

bluebird bio

Sunway Biotech

SIBIONO

AnGes

Human Stem Cells Institute

Orchard Therapeutics

Gene Therapy On Cardiovascular Disease Product Segment Include:

Viral Gene Therapy

Non-Viral Gene Therapy

Gene Therapy On Cardiovascular Disease Product Application Include:

Neurological Diseases

Cancer

Other

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Gene Therapy On Cardiovascular Disease Industry PESTEL Analysis

Chapter 3: Global Gene Therapy On Cardiovascular Disease Industry Porter’s Five Forces Analysis

Chapter 4: Global Gene Therapy On Cardiovascular Disease Major Regional Market Size and Forecast Analysis

Chapter 5: Global Gene Therapy On Cardiovascular Disease Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Gene Therapy On Cardiovascular Disease Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Gene Therapy On Cardiovascular Disease Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Gene Therapy On Cardiovascular Disease Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Gene Therapy On Cardiovascular Disease Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Gene Therapy On Cardiovascular Disease Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Gene Therapy On Cardiovascular Disease Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Gene Therapy On Cardiovascular Disease Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources


1 Gene Therapy On Cardiovascular Disease Market Overview
1.1 Product Definition and Statistical Scope
1.2 Gene Therapy On Cardiovascular Disease Product by Type
1.2.1 Global Gene Therapy On Cardiovascular Disease Market Size by Type, 2023 VS 2024 VS 2030
1.2.2 Viral Gene Therapy
1.2.3 Non-Viral Gene Therapy
1.3 Gene Therapy On Cardiovascular Disease Product by Application
1.3.1 Global Gene Therapy On Cardiovascular Disease Market Size by Application, 2023 VS 2024 VS 2030
1.3.2 Neurological Diseases
1.3.3 Cancer
1.3.4 Other
1.4 Global Gene Therapy On Cardiovascular Disease Market Revenue Analysis (2019-2030)
1.5 Gene Therapy On Cardiovascular Disease Market Development Status and Trends
1.5.1 Gene Therapy On Cardiovascular Disease Industry Development Status Analysis
1.5.2 Gene Therapy On Cardiovascular Disease Industry Development Trends Analysis
2 Gene Therapy On Cardiovascular Disease Market PESTEL Analysis
2.1 Political Factors Analysis
2.2 Economic Factors Analysis
2.3 Social Factors Analysis
2.4 Technological Factors Analysis
2.5 Environmental Factors Analysis
2.6 Legal Factors Analysis
3 Gene Therapy On Cardiovascular Disease Market Porter's Five Forces Analysis
3.1 Competitive Rivalry
3.2 Threat of New Entrants
3.3 Bargaining Power of Suppliers
3.4 Bargaining Power of Buyers
3.5 Threat of Substitutes
4 Global Gene Therapy On Cardiovascular Disease Market Analysis by Regions
4.1 Gene Therapy On Cardiovascular Disease Overall Market: 2023 VS 2024 VS 2030
4.2 Global Gene Therapy On Cardiovascular Disease Revenue and Forecast Analysis (2019-2030)
4.2.1 Global Gene Therapy On Cardiovascular Disease Revenue and Market Share by Region (2019-2024)
4.2.2 Global Gene Therapy On Cardiovascular Disease Revenue Forecast by Region (2025-2030)
5 Global Gene Therapy On Cardiovascular Disease Market Size by Type and Application
5.1 Global Gene Therapy On Cardiovascular Disease Market Size by Type
5.2 Global Gene Therapy On Cardiovascular Disease Market Size by Application
6 North America
6.1 North America Gene Therapy On Cardiovascular Disease Market Size and Growth Rate Analysis (2019-2030)
6.2 North America Key Manufacturers Analysis
6.3 North America Gene Therapy On Cardiovascular Disease Market Size by Type
6.4 North America Gene Therapy On Cardiovascular Disease Market Size by Application
6.5 North America Gene Therapy On Cardiovascular Disease Market Size by Country
6.5.1 US
6.5.2 Canada
7 Europe
7.1 Europe Gene Therapy On Cardiovascular Disease Market Size and Growth Rate Analysis (2019-2030)
7.2 Europe Key Manufacturers Analysis
7.3 Europe Gene Therapy On Cardiovascular Disease Market Size by Type
7.4 Europe Gene Therapy On Cardiovascular Disease Market Size by Application
7.5 Europe Gene Therapy On Cardiovascular Disease Market Size by Country
7.5.1 Germany
7.5.2 France
7.5.3 United Kingdom
7.5.4 Italy
7.5.5 Spain
7.5.6 Benelux
8 China
8.1 China Gene Therapy On Cardiovascular Disease Market Size and Growth Rate Analysis (2019-2030)
8.2 China Key Manufacturers Analysis
8.3 China Gene Therapy On Cardiovascular Disease Market Size by Type
8.4 China Gene Therapy On Cardiovascular Disease Market Size by Application
9 APAC (excl. China)
9.1 APAC (excl. China) Gene Therapy On Cardiovascular Disease Market Size and Growth Rate Analysis (2019-2030)
9.2 APAC (excl. China) Key Manufacturers Analysis
9.3 APAC (excl. China) Gene Therapy On Cardiovascular Disease Market Size by Type
9.4 APAC (excl. China) Gene Therapy On Cardiovascular Disease Market Size by Application
9.5 APAC (excl. China) Gene Therapy On Cardiovascular Disease Market Size by Country
9.5.1 Japan
9.5.2 South Korea
9.5.3 India
9.5.4 Australia
9.5.5 Indonesia
9.5.6 Vietnam
9.5.7 Malaysia
9.5.8 Thailand
10 Latin America
10.1 Latin America Gene Therapy On Cardiovascular Disease Market Size and Growth Rate Analysis (2019-2030)
10.2 Latin America Key Manufacturers Analysis
10.3 Latin America Gene Therapy On Cardiovascular Disease Market Size by Type
10.4 Latin America Gene Therapy On Cardiovascular Disease Market Size by Application
10.5 Latin America Gene Therapy On Cardiovascular Disease Market Size by Country
10.5.1 Mecixo
10.5.2 Brazil
11 Middle East & Africa
11.1 Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size and Growth Rate Analysis (2019-2030)
11.2 Middle East & Africa Key Manufacturers Analysis
11.3 Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size by Type
11.4 Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size by Application
11.5 Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size by Country
11.5.1 Saudi Arabia
11.5.2 South Africa
12 Market Competition by Manufacturers
12.1 Global Gene Therapy On Cardiovascular Disease Market Revenue by Key Manufacturers (2020-2024)
12.2 Gene Therapy On Cardiovascular Disease Competitive Landscape Analysis and Market Dynamic
12.2.1 Gene Therapy On Cardiovascular Disease Competitive Landscape Analysis
12.2.2 Global Key Manufacturers Headquarter and Key Area Sales
12.2.3 Market Dynamic
13 Key Companies Analysis
13.1 Biogen
13.1.1 Biogen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.1.2 Biogen Gene Therapy On Cardiovascular Disease Product Portfolio
13.1.3 Biogen Gene Therapy On Cardiovascular Disease Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.2 Novartis
13.2.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.2.2 Novartis Gene Therapy On Cardiovascular Disease Product Portfolio
13.2.3 Novartis Gene Therapy On Cardiovascular Disease Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.3 Gilead Sciences
13.3.1 Gilead Sciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.3.2 Gilead Sciences Gene Therapy On Cardiovascular Disease Product Portfolio
13.3.3 Gilead Sciences Gene Therapy On Cardiovascular Disease Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.4 Sarepta Therapeutics
13.4.1 Sarepta Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.4.2 Sarepta Therapeutics Gene Therapy On Cardiovascular Disease Product Portfolio
13.4.3 Sarepta Therapeutics Gene Therapy On Cardiovascular Disease Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.5 Alnylam Pharmaceuticals
13.5.1 Alnylam Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.5.2 Alnylam Pharmaceuticals Gene Therapy On Cardiovascular Disease Product Portfolio
13.5.3 Alnylam Pharmaceuticals Gene Therapy On Cardiovascular Disease Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.6 Amgen
13.6.1 Amgen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.6.2 Amgen Gene Therapy On Cardiovascular Disease Product Portfolio
13.6.3 Amgen Gene Therapy On Cardiovascular Disease Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.7 Spark Therapeutics
13.7.1 Spark Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.7.2 Spark Therapeutics Gene Therapy On Cardiovascular Disease Product Portfolio
13.7.3 Spark Therapeutics Gene Therapy On Cardiovascular Disease Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.8 Akcea Therapeutics
13.8.1 Akcea Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.8.2 Akcea Therapeutics Gene Therapy On Cardiovascular Disease Product Portfolio
13.8.3 Akcea Therapeutics Gene Therapy On Cardiovascular Disease Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.9 bluebird bio
13.9.1 bluebird bio Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.9.2 bluebird bio Gene Therapy On Cardiovascular Disease Product Portfolio
13.9.3 bluebird bio Gene Therapy On Cardiovascular Disease Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.10 Sunway Biotech
13.10.1 Sunway Biotech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.10.2 Sunway Biotech Gene Therapy On Cardiovascular Disease Product Portfolio
13.10.3 Sunway Biotech Gene Therapy On Cardiovascular Disease Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.11 SIBIONO
13.11.1 SIBIONO Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.11.2 SIBIONO Gene Therapy On Cardiovascular Disease Product Portfolio
13.11.3 SIBIONO Gene Therapy On Cardiovascular Disease Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.12 AnGes
13.12.1 AnGes Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.12.2 AnGes Gene Therapy On Cardiovascular Disease Product Portfolio
13.12.3 AnGes Gene Therapy On Cardiovascular Disease Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.13 Human Stem Cells Institute
13.13.1 Human Stem Cells Institute Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.13.2 Human Stem Cells Institute Gene Therapy On Cardiovascular Disease Product Portfolio
13.13.3 Human Stem Cells Institute Gene Therapy On Cardiovascular Disease Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.14 Orchard Therapeutics
13.14.1 Orchard Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.14.2 Orchard Therapeutics Gene Therapy On Cardiovascular Disease Product Portfolio
13.14.3 Orchard Therapeutics Gene Therapy On Cardiovascular Disease Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
14 Industry Chain Analysis
14.1 Gene Therapy On Cardiovascular Disease Industry Chain Analysis
14.2 Gene Therapy On Cardiovascular Disease Industry Raw Material and Suppliers Analysis
14.2.1 Upstream Key Raw Material Supply Analysis
14.2.2 Raw Material Suppliers and Contact Information
14.3 Gene Therapy On Cardiovascular Disease Typical Downstream Customers
14.4 Gene Therapy On Cardiovascular Disease Sales Channel Analysis
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology/Research Approach
16.2 Research Scope
16.3 Benchmarks and Assumptions
16.4 Date Source
16.4.1 Primary Sources
16.4.2 Secondary Sources
16.5 Data Cross Validation
16.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings